Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2-Positive Solid Tumors.
Xu SX, Wang L, Ip P, Randhawa RR, Benatar T, Prosser SL, Lal P, Khan AN, Nitya-Nootan T, Thakor G, MacGregor H, Hayes DL, Vucicevic A, Mathew P, Sengupta S, Helsen CW, Bader AG.
Xu SX, et al.
Cancer Immunol Res. 2025 Jan 9;13(1):35-46. doi: 10.1158/2326-6066.CIR-24-0138.
Cancer Immunol Res. 2025.
PMID: 39404622
Free PMC article.